HPGC Renmintongtai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
HPGC Renmintongtai Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥894.3M, which brings its debt-to-equity ratio to 31.1%. Its total assets and total liabilities are CN¥7.0B and CN¥4.2B respectively. HPGC Renmintongtai Pharmaceutical's EBIT is CN¥356.9M making its interest coverage ratio 90.6. It has cash and short-term investments of CN¥795.9M.
Key information
31.1%
Debt to equity ratio
CN¥894.28m
Debt
| Interest coverage ratio | 90.6x |
| Cash | CN¥795.87m |
| Equity | CN¥2.87b |
| Total liabilities | CN¥4.16b |
| Total assets | CN¥7.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600829's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥4.0B).
Long Term Liabilities: 600829's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥145.1M).
Debt to Equity History and Analysis
Debt Level: 600829's net debt to equity ratio (3.4%) is considered satisfactory.
Reducing Debt: 600829's debt to equity ratio has increased from 23.7% to 31.1% over the past 5 years.
Debt Coverage: 600829's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 600829's interest payments on its debt are well covered by EBIT (90.6x coverage).